(Q54070449)

24 May 2018

title

Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk. The Risk Factor Intervention Study Group. (English)

1 reference

24 May 2018

0 references

Agewall S

1

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 November 1999

1 reference

24 May 2018

Journal of Internal Medicine

published in

1 reference

24 May 2018

volume

246

1 reference

24 May 2018

issue

5

1 reference

24 May 2018

page(s)

489-495

1 reference

24 May 2018

von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00543.X

Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00543.X

Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00543.X

Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00543.X

Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00543.X

The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00543.X

Body weight is more important than family history of hypertension for left ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00543.X

Increased fibrinogen levels in the offspring of hypertensive men. Relation with hyperinsulinemia and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00543.X

The pathogenesis of atherosclerosis--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00543.X

Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00543.X

Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. Risk Factor Intervention Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00543.X

Increased prothrombin fragment 1 + 2 and D-dimer in first-degree relatives of type 2 diabetic patients. Prethrombotic state in relatives of type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00543.X

Insulin resistance and cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00543.X

Effect of Antihypertensive Drugs on Insulin, Glucose, and Lipid Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00543.X

10.1046/J.1365-2796.1999.00543.X

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018